Study: NCT01638104

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANX-042
Description: Reconstituted in Sterile Water for Injection, United States Pharmacopeia (USP) and administered by 12 hour continuous intravenous infusion with 5% dextrose in water (D5W), United States Pharmacopeia (USP)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANX-042
Description: Reconstituted in Sterile Water for Injection, United States Pharmacopeia (USP) and administered by 12 hour continuous intravenous infusion with 5% dextrose in water (D5W), United States Pharmacopeia (USP)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANX-042
Description: Reconstituted in Sterile Water for Injection, United States Pharmacopeia (USP) and administered by 12 hour continuous intravenous infusion with 5% dextrose in water (D5W), United States Pharmacopeia (USP)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANX-042
Description: Reconstituted in Sterile Water for Injection, United States Pharmacopeia (USP) and administered by 12 hour continuous intravenous infusion with 5% dextrose in water (D5W), United States Pharmacopeia (USP)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANX-042
Description: Reconstituted in Sterile Water for Injection, United States Pharmacopeia (USP) and administered by 12 hour continuous intravenous infusion with 5% dextrose in water (D5W), United States Pharmacopeia (USP)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANX-042
Description: Reconstituted in Sterile Water for Injection, United States Pharmacopeia (USP) and administered by 12 hour continuous intravenous infusion with 5% dextrose in water (D5W), United States Pharmacopeia (USP)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANX-042
Description: Reconstituted in Sterile Water for Injection, United States Pharmacopeia (USP) and administered by 12 hour continuous intravenous infusion with 5% dextrose in water (D5W), United States Pharmacopeia (USP)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANX-042
Description: Reconstituted in Sterile Water for Injection, United States Pharmacopeia (USP) and administered by 12 hour continuous intravenous infusion with 5% dextrose in water (D5W), United States Pharmacopeia (USP)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANX-042
Description: Reconstituted in Sterile Water for Injection, United States Pharmacopeia (USP) and administered by 12 hour continuous intravenous infusion with 5% dextrose in water (D5W), United States Pharmacopeia (USP)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANX-042
Description: Reconstituted in Sterile Water for Injection, United States Pharmacopeia (USP) and administered by 12 hour continuous intravenous infusion with 5% dextrose in water (D5W), United States Pharmacopeia (USP)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered once by 12 hour continuous intravenous infusion with D5W (USP)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered once by 12 hour continuous intravenous infusion with D5W (USP)